Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Besterman

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Atherosclerosis|March 1, 1977
Plasma and erythrocyte lysolecithin schistosomiasis mansioniM P Gillett, E M Besterman
Clinical Cardiology|February 1, 1982
A clinical evaluation of sustained release metoprolol durules in the treatment of angina pectorisM B Comerford, E M Besterman
Thrombosis Research|June 1, 1974
A possible thrombo-protective role for plasma lysolecithin in manM P Gillet, E M Besterman
British Heart Journal|April 1, 1974
Proceedings: Value of isometric exercise in assessment of left ventricular functionR J Vecht, E M Besterman
Lancet (London, England)|January 15, 1972
Altered plasma-lysolecithin levels and plateletsE M Besterman, M P Gillett
Atherosclerosis|November 1, 1971
Inhibition of platelet aggregation by lysolecithinE M Besterman, M P Gillett
Atherosclerosis|July 1, 1972
A comparison of the effects of saturated and polyunsaturated lysolecithin fractions on platelet aggregation and erythrocyte sedimentationE M Besterman, M P Gillett
Annals of Clinical Research|February 1, 1982
A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertensionM B Comerford, E M Besterman
Lancet (London, England)|March 11, 1978
Disopyramide in myocardial infarctionP H Kidner, E M Besterman
Scottish Medical Journal|January 1, 1977
Some observations of the long-term clinical response to selective beta-blockade (metoprolol) in angina pectorisM B Comerford, E M Besterman
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Atherosclerosis|March 1, 1977
Plasma and erythrocyte lysolecithin schistosomiasis mansioniM P Gillett, E M Besterman
Clinical Cardiology|February 1, 1982
A clinical evaluation of sustained release metoprolol durules in the treatment of angina pectorisM B Comerford, E M Besterman
Thrombosis Research|June 1, 1974
A possible thrombo-protective role for plasma lysolecithin in manM P Gillet, E M Besterman
British Heart Journal|April 1, 1974
Proceedings: Value of isometric exercise in assessment of left ventricular functionR J Vecht, E M Besterman
Lancet (London, England)|January 15, 1972
Altered plasma-lysolecithin levels and plateletsE M Besterman, M P Gillett
Atherosclerosis|November 1, 1971
Inhibition of platelet aggregation by lysolecithinE M Besterman, M P Gillett
Atherosclerosis|July 1, 1972
A comparison of the effects of saturated and polyunsaturated lysolecithin fractions on platelet aggregation and erythrocyte sedimentationE M Besterman, M P Gillett
Annals of Clinical Research|February 1, 1982
A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertensionM B Comerford, E M Besterman
Lancet (London, England)|March 11, 1978
Disopyramide in myocardial infarctionP H Kidner, E M Besterman
Scottish Medical Journal|January 1, 1977
Some observations of the long-term clinical response to selective beta-blockade (metoprolol) in angina pectorisM B Comerford, E M Besterman
Pageof 4